Showing results 1 to 8 of 8
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
| 3-Jan-2023 | ||||
A Review on Lopinavir/Ritonavir Journal:Medical Progress (Hong Kong Edition) | 2005 | 19 | ||
Association between recent antibiotic usage and early immunogenicity of COVID-19 BNT162b2 vaccine Proceeding/Conference:United European Gastroenterology Week, United European Gastroenterology (08/10/2022-11/10/2022, , , Vienna, Austria) | 8-Oct-2022 | |||
COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection Journal:Asian Pacific Journal of Allergy and Immunology | 1-Feb-2023 | |||
Gut microbiota composition predicts longer-term immunogenicity after two doses of CoronaVac. Proceeding/Conference:Asia Pacific Digestive Week (Bangkok, Thailand) | 1-Jan-2023 | |||
Gut microbiota is associated with persistence of longer-term vaccine immunogenicity after two doses of BNT162b2 Proceeding/Conference:United European Gastroenterology Week, United European Gastroenterology (14/10/2023-17/10/2023, , , Copenhagen, Denmark) | 14-Oct-2023 | |||
Proton pump inhibitors associated with severe COVID-19 infection among two-dose but not three-dose vaccine recipients Proceeding/Conference:Asia Pacific Digestive Week - APDW2023 (06/12/2023-09/12/2023, , , Bangkok, Thailand) | 6-Dec-2023 | |||
| 2009 | 130 |